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ABSTRACT 
/Jad:grountl: IJ,YlUpidmmia Is a commonly a.,·sot•!atcrtl <.'Qmurhiclfl)' Itt fllJtler.ts with (.'hronk Kidney 
Ui.\l!tlst. It has !Htu jhown tn mc:rease the ril•k of c(lrdlova.tcular t •·ent.o; In tht.,·c puaents. 1'h1.Y ~ttulyt~l"'s :o 
hiJ.:I~Ught IN l'elaiH.mship bPtM'eetJ diffor,•t'l/ ~erum lipid indtc~s and t't'nnl fom:!IOII at inrlicul~ll by 
C,'Jum~~mur Filtration Ru.tff 
tt.lellt(H/nlt~gy: thiJ' was a ~tl'tispet·ti'-'t sttu'fy wlt.icl: 0110/yz~d data from patiwls with cllmnic ki:tfne,v 
d/s(!a:;~ "Jtu "lsittrd the N.:phrtiluJ;Y <,:JinJ,. l?ftlu: Jo,r UniWt81ty 7~th·hing ffo.,pitalji-om / 11 October to J }11 
lle<"ember 10 I J 
R~:ru/1$: 01J of tiN: 110 pu!lellts.tllldied. 6/.I'X lit'n malt!-r T1te mtOit Q~ u}lh< populalwn wcas 551-/ . 
I 6. d )'tars. 60%of:rubjt•cU hat tfyslipidaemia Estfma:ed(i/umttrulur Ff!trcdiun Rate coo·<lah·d" irh HDI~ 
cholcst~rol. b1111tot with total t lwlesttt'O/ or trlglyceri<ie. 
C'onclusimt: Ot'fr' half o/rltt study popr,futiun had J·ome fnrm of'dertm~rmem i.tl sent'" ltpltfJ· Thi$ ua.' 
mdtV pre~a'*nl (lnfOilgftnroltt "tlbj~~IS. R~ufm nw.m,trtllf~N fl//!lSting SFI'IIm lipMs is e.Menlt'ul in chtr.,.ir 
kiclr.q(01Mt'Ufc to d~teclllhff()rmafi!les earl}' O'f •-elf as m011itor pnJg'NstQ{trrutnreriL 
IIACKCfiOIIND 
Chrvnh.: kidney disease 15 ~:haraeteri7..ed by lt.t: 
present~ of o m.ork<:r o( kidney dantt~ge lor a 
dliralion of 3 I»>nlhs or lon~cr and/or n glolliCIU1ar 
fi.Jtr:nion r.1tC' ur Jess 'h~n 60nllfmin/l 71mlii'J 
Ma~c:rs or rc.'nal cb.."tWge t.ncluck 3.b!lotmahlic." on 
witt.alysj:s (such u.s protcinunn),. rndiolot;;:) C 5uchas 
n;dtl.4;cd n:mJI S l71!!'\)()r histoh>~)· It iscstimtth.::cJ that 
Chronic KiJuoJ~· Di~"c ot\Cao:t$ (Jvcr SO n'lillion 
~rsons world\Mde~. In Ni~t.:-ria. it is rcpl)rted thal 
tC'nol3 fatJurc ~H'lls tOr about 8~ of hn~iu&al 
o<Jml~St(HU r he pre\'afenc.'C in I he COunt!') ratlg\.'$ 
frurr. as lov. "" ! 9.9'/~t'" to n .. high as 45 5,.~ 
(li:pcndint; on the charactvr•stics u l' 1hc stu(ly 
popuJauon l"h~ mctab<,lic chan£e~ seen in 
Lhro!w. K:dm.') D•~cil•u.: (CK.O) incl lld~ 
~crartgemtnh in $t':Um hpeJ p;:.-.m:c-:CB '-UCh rut 
tnt:l)'c¢nu.!:-.. tOtill cht.tl\!!.ll.:ft11 a11d I ligh l.h:mtll) 
J.Jruprocctn ( H IJL) chQicstcrut Tt•csc chang.::. ttr.: 
h.rht\\ 11 ll• bc~;m early in tlw (lmgres~mn ''' <.:KJ)'. 
:mJ clHiirtd~<cnua 1n tnrn acce-!emtL''- lhc 
P:\"l.!n:c;;. tcllti ,,f l"U) n.._ ... conunCI'k\:rner.l ut 
"'·'!"~ls m 1' n•'l tr.:.:>:!..·••ant~ k.w:f 14 lt:c tt,r,-.;lio•• 
of Gyshpidactnia. It m.y c\cn hl.'\o.OOl~ tllOR' SC\<"N 
m those commencinc pc:n1ooeat Uiulysu or in those: 
who have had a rennl traosplan!•. l)yslipidaemin 
a!'so<:inled with CK I) is important \lcc:uusc 11 f\lrlher 
iorrea~~ the risk of C!'rdiu\•asculo.~r c .. e.ots lik( 
stroh and myoe.~rdanlinf.arction' In 1his stud'/. we 
aim 10 determine lh~ r~·;l(t'I'IC~ tt( d)'sfip;:dr,emia 
amon¥ puhl!nts w ith CRD and ai$Cith~ rd:.Jions.lup 
bch,~c~n GJ(Imcmln•· l,.iltrotion Rtttt.:! ( CFR) :md the 
vnnou'i ~rum lipid mdit:C$. 
MATt:kiAI..SAN0:\1£1'HODS 
The rc<:ord.~ of all puttents Wlth C.:KU seen 3l lh~o: 
Ne("h•·o!o.~,;y Clin i~ 1>f' the Jos Univt:flit>' leachin~ 
llosp11ul ffom I" October 2013 1u ,) I* December 
2013 we-re rt'vi~~t"d The Jm:o t 'n •'~'n.IIY lcacmn,: 
HnsptUaJ Jot 01 t:rttllf} J,.....,Jith c:m• fa-·dtt) toca~ed tn 
1~. ca(lltal or Pl~tcau Stnt-.:-. North r \.'tllral N1:-,"---ri:. 
D:.thl obt .. an~d for cau::l• !'Uhji:ct ind uJcd US."'· !!tnd .... c 
Oody Mn-.s ln<IC!X (OMII. ~~.·nul! c-re;~unm ... •. 
1r-.::.:11mcnt ~latus '-"1\h (,1atino.: illld !~t:.\11 1 1! )c\·;;1:- (•f 
Sl'rum tot.ll chok:-~h:mt l iD I 'hl~k:Stt:"r'' .n~ 
\n~l~cCfKk."S. ('KD \,,, .. defu'k..'\: .... .. n \."<<Uila!("'1 
Serum Lipid Indices ar1d Renal Frmction among Persons with Chronic Kidney Disease in Jos 
GFR ( eGFR) of less than 60ml/minil. 73m2• eGFR . Table 1: Frequency distribution of the different stages of 
was calculated from the age and creatinine levels CKD 






eGFR = (32788)(Age·0.203)(Creatinine- w 4)( 0.742 
if female)( 1.21) 
Based on eGFR values, CKD was staged into 
Stages 3 ( eGFR 59 to 30ml/min), 4 ( 29 to 
15mlfmin) and 5 or End Stage Renal Disease 
(eGFR < 15ml/min) according to the National 
Kidney Foundation Staging". 
Dylipidaemia was defined as elevation of total 
cholesterol ( > 6.5mmol/L) or triglyceride levels 
(> l.75mmol/L) , and/or a reduction in HDL 
cholesterol levels ( < lmmol/L men; <1.2mmol/L 
women). The reference values used here are those 
of the Chemical Pathology Laboratory of the Jos 
University Teaching Hospital. 
STATISTICALANALYSIS 
This was done using the EPl Info statistical 
software ( version 7.0). Quantitative variables ( 
age, BMJ, eGFR, Jipid indices) were expressed as 
means±standard deviation while categorical 
variables ( Gender, Stage of CKD, treatment with 
statins) were expressed as proportions. The t test 
and the Chi square test were used in the comparison 
of means and proportions respectively. The 
Pearson Correlation coefficient and Linear 
regression analysis was used to assess the 
relationship between eGFR and the different lipid 
indices. In all cases, p value< 0.05 was considered 
statistically signi.ficant. 
RESULTS 
The study population comprised 11 0 subjects. 
61.8% were males. The mean ages of males and 
females were 56±16.7 and 53±16.5 years 
respectively. There was no statistically significant 
difference between the two values ( p=0.388). 
66.4% of the population were greater than 50 years 
of age. Majority of subjects had sta&e 3 CKD 
(71.8%). Mean BMI was 25.8±2.2kg/m· for males 
and 27 .0±2.9kg/m2 for females. The difference was 
statistically significant ( p =0.024). Dyslipidaemia 
was present in 54.4% of males and 69.1% of 
females ( X2 = 2.32; df = I; p=O.l28) 
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3 79 71.8 
["4 --10 9.J 
5 21 19.1 
Table 2: Two by two table of gender versus lipid status 
Dyslipidaemia No TOTAL 
4Ysl!I>_idaemia 
Males 37 (33.6%) 31 (28.1 %) 68 
Females 29(26.3%) 13 (11.8%) 42 
66_(60%) 44 {400/o) 110 
J .l OR = 1.87; X - 2.32, df - 1, p -0.128 
A positive correlation was observed between eGFR 
and HDL( r=0.49; Ftest = 10.63; p""0.0015). There 
was no correlation between eGFR and total 
cholesterol ( r=-0.008; F = 0.0072; p=0.932). There 
was also no correlation between eGFR and 
triglyceride ( r = -0.06; F=0.38; p=0.534). In both 
instances, the absence of correlation persisted even 










Figure 1: scatterplot of eGFR versus HDL 
-Cholesterol ( r""0.49) 
DISCUSSION 
The majority of our study population were males ( 
61.8%). Some studies have reported that Chronic 
Kidney Disesase is more prevalent in men than 
women'2 while other studies report the reverse'3 • 
This depends on factors such as the stage of CKD 
being considered and the underlying aetiology of 
the disease. The mean ages of males and females in 
our study population were similar to findings 
elsewhere14• Other reports however give a relatively 
lower mean age for patients with CKD'S, including 
some studies in Nigeria'6"w .The relatively higher 
24 
age: in lh~s S1tlli}· coold be ·xpla ill4:d by lhe f~ret dltlt 
m~·ority (66.4%) t,f tilt :subj~ct:; were albo\'e ~V 
years of Qgc:. This is « msWermg the fact thai the 
risk of dc:velopi ng C: K IJ i I"~CrCll~~~ wil h l•dvan i.n~~; 
ag,t dUC t0 the f;(peC:Ied deC~ fnC tn renal fURCtiOR1L. 
The l'lrevnte nee of d) sl ipkl.~~mi a v- i!S hi{!;l-ter 
among female subjects_ lntere.!>ti ngly, the fema!...-
~~b'ect!. hmJ .11 s i .~nillc-1nt ly high~l' meatt BMI 
(27.0+1·2.tJ'-.Wm: ) com~r~ with males ~2.5.&+/-
22kgfm')- Whelht:r or 1101 lhi!:. &.:omparative ly 
greah:r d..:gn::e of a<Jj posacy n 1llong lcm.ale subjects 
is re5.ponsio'e or the1r higher prc\"aJcnce o r' 
dyslip•da¢'mi~t is ool clear, us. there lfl:a.)' be n 
(!l'rmpl~ int.,;rncl ton of otbc-r f::H:ft)~. 
\Ve knmdn\lt lfu'lt HDL sh~iWN si~nifi~'1•1t~i\ivc 
t:Qrrehnion wi!h eGFR. This ' :..:; lhc fmding or 
·IJfit'C other work:ers' ,-~ n,~~ reb11 mnshap between 
HOt ond eGFR wa~ maintaineJ e\l·en after 
001UStili1y rorconfound~rs su ha"'>:l e. B~T and o~ 
of sra:tin~. Krikken t!C af' r~po rl~d nc=".g.ali ,·e 
~rrrchmoo bclwcen HDL and c-t1f.R . The :;tuJ:~ 
h(lwcvrc.t diUi=~ from ours ns 11 was done runon:~ 
p~:r54Jm without C.KD(<JFJt;..Wmiimin} "n'RJJ were-
not on ~ipiLt l ,uw~rin~ osg~nlli. There was no 
correlation bet"'~n lola! d'Hllc:slero I, tr jglyc.erides 
and .;GfiR i11 the study JX>pu l :~tion_ In is 1indin~ i:; 
.5:m&lw- to [hat made b)' A~ aha el a 1·:: who found no 
~lg.nifica:nl d i ffcrern::e ~1 w~-cn •~a I cholesteroJ and 
ttiE;I)"cc:rid.c lc\·~ls ~mon~ md i qdual s with End 
Sta,ge- Re.n~l Di.s-eilSc -.:ornran:d wi•h ht:ahh) 
rontrots. 13t llum et al 3' und .Seidulhth ~t Ill'' "'ert' 
11ble to demonsrrnte t1 !\ign i 1k~mt correlrttion 
hetV.tl!el1 10ti'1J ~hok.skm anti {jFJC lilt.:) slm.licd 
only indi viduals •.vjth d1J~til.' nephropathy (our 
study inch d~d CK D from diff~re11t ae~iolo!J.h."! )-
CONCl..U ~tON 
Abr:\'Omlalilics in ~rum hpid indices are common 
in pal iencs. with Chr01'ttc Kidney Oi-'ie3S<;:- lf lc.ft 
untrtalt·d, 11 1~o:y oCiJll ancr .. ·;;tst: the risk of 
ClJdjo\·ascuJar cvcn'ls and Wf1rsen: the o '"~rai l 
prognosis m such pat~c~11.t~- Regulot screening n11d 
earl)' c:ommencemen1 of th era.py is ~..-sse nti<t.l. 
JU:.FERENCIJ.S 
t, Lc\'C~,' A-S., Eckhardt K.C., T5~Jkamoto Y., 
Levin A , Coresh 1-. Rl-s3e"rC J. ~ Delinlliun and 
elassdic:al]on of C KD - po~i t i<11n s1:11 r:merJI 
from the: l<Jdnfy IJjscase l.mptQvin~ Gk:b-al 
Out..:tJme Kfdm~)' lnJ 1005.-6:2089~11()1) 
2. Josef C, Brad C.A.~ TQm 'G. , Garabed E .. 
Andl'eW S.L"7 Ptr!valenot of Chronioc lddne) 
Dis.:iJ:s~ and reJ uced n:nill lunc:i ton in lJ S. 
.... 
4. 
pofllllohon Am J Ridney V~.wu t!~ 2()0.f .- .,~I : l -
12 
/\kHisoJa A._ Odl!!\:.:mmi \V.O . Ot.mnj t I 0 .• 
U.d1po 0.0 A~ Oi:scooc;s caus4~g :tuunx~ 
renal tbi lun.: tn 1'-; i ~e rta- a prusp::-c~i \ ·e lt1dy of 
I OOcascs.~,fr J ftfijdSt i J999,-6(J.J : 198-101 
Abioye-kuteyi E_A., AkinStllllA . Ezcoma LT .. 
Rt:na! di se.n~e : tbe need fOr- eommAIIlily l'!Qs.ed 
!::crecni ng m •1ro I Nag(m~ A fr J JL.f~d l'm~·t 
1 ~9~.- 6.-J 9~'-2(}J 
5 N\"ankvro EA. wan -wo B, Mubi B__ 
PreynJ ~:~nee of lmpt:dt1..4.1 n:rn.~l h.mcuon m 
flms.p ita I i:ted h ~ p-e 1'1,t n:si ..  c pa ti cots in 
Maidul;tUJ j N i~cria Tire ln~~rnf!l .h:mmal of 
McJ1ci11e 1006:6_· J 
6. Flist'r D .• Pacrm G .• f..figcUt ikcr R_, Kmltzy 
W.A.. Pro~cr IL lnsulm ~!>istance dnd 
hy rteri.nsuJ i rtlle mm £llfC ~lrcilcly plc.sr m UJ 
pat 1enl::i v.o i lJ1 i ~i pient ~nal disease Ki<incl·' /nt 
J 99.JI:5J_· /1-fJ-1 J-17 • 
7, f rierl I..L Otchru-d J .L Kn~io;kc R L , l-::flcct~ 
o hp1d re.duction uta pmgrc~ston 0 t rcooal 
dlSCilSC·a. n1cta an<.1ly~ i ~ Kidru!J-' hH 
2001 :J9(JJ ·1r50-l69 
8. Atlme•~ P_O, Stlllludsson O .G., Moberh J. 
Juhans54.'H'I . i\_C"., Li on~me.n S.. APl.' li 
conlainif\.!1, l i!W'protei11~ in rl'"~tl fmlurc- t~ 
rcl~•tio n lu m~'de uf d i.Llysi~ ~·it/rr(!.y 1m 
/'I<)'/ • 5~. 15Jti· J 595 
9 Lond<\n G.M .• r)rueke T. R .• Adl~QSClctosis. 
arn.l Arlcn!Jsck-rosJs jn chronic renm' t~Uure 
K id"('Y frrr I YY7,-51 ·16 :-~- i 69j 
10. K.J ihno:Je K.S .. SCeve n~ P F .• f."aglesiDile G., 
1-:nt!!htS .• Crader J.t .. Lkl;~ney M.P .• A..-:cu:racy 
o t t.bc Modi li:col I on of D ict in Rcna.i LJis.ca.sc 
~uu.ly and th~ dtronie ~;dnt:y c:li~r:u e 
Cj idem i.olog} cquat iu,n lot t?SlUnill iun of 
glmncruJar nltratiun rnle in ahe e~dc;-ly Am J 
K.uJ Dis 2011:61 . _~i-66 
II . L~vey A.S .. f'o~h J • l3;1~k E .. .1\..am;,z A.T., 
L ... , in A.. Stdlcs M. W .. Natiollill Ktdnc:)' 
Fcundmiun pidt..'lit..~ ~u!dctiru:~ lv.r chronk: 
kadncy d ise:wse: e\•3lu ;lUQn, ('Lnssi lication ~11d 
s t r tt t i fi c a t i o n A JJ n f rH " r rt M !! rl 
!OVJ: 1 ]Y_·l 17-147 
1-l. Gl~s.soc.k R J.. \Vm~~s c._ An epid~mtt' of 
chruni~ kidney distnsa: fact at fict.h.~n? 
Mrplrroll Jiui 1rmrp{,(ml 1008:l ]-1 ll --1 J 7 J 
1.3. Yu M . .K__ lyle~ CR. 'llentshaw L/\ .. Young 
B.A_, ki sk. factvrs. age 41nd sex dttferem.:~ in 
chronic kidneydjsease prevalence in a diabetic 
cohort: lhe p;Hhw~y study Am J f rtpln·al 
2itl _, j(} 24)·151 
14. Anup3J!la YJ., UmaG. Prev•lenceorchronic 
kidney disease among adults in o I'UI\l) 
oooununity in South JOIJia~ reMSilS from the 
Kidney Disea..<e S<:reening ( KIDS) ptOJOCl 
Inclion J Ntphro/ 1014; • ·publication 
b.J.Jp;/ltrW£indiqajnc.ohrqLuqlncrqrimanjcJ 
u 
IS. Oooneratne L.K .. Runuwc~ra A.KP .. 
Liyamunthdu;i N.P., OumtWtttdlmc N .. 
LOJ1crollc ltD., llpidemiolosy of chronic 
kidney disease in a Sri Lankan pOpulo lion lntJ 
11/a/Jrttes DevCtries 2008; 18·6{)-64 
19. lew" O .. llayncs R.. L•ndrcy M.J .. lipids in 
chronic ktdnc) d,..,... R<n(.u,.. 21)10.J6l7· 
.IJ 
20. Wang F .. / hen& ! . Yo r•. I. ,.,f ... Hlo Y. SJt<"'! 
L.. Assuci~uon nf 1101 . wilh eslimated 
glumcrul:u Jiltrauon rotc m 3 commumt}' 
basod pnpulooion 111uv O•e 201 3:6(//) •t•7Y136 
21 . Kri.,kcn J.A., Onn:;cvoort H .. T .. JJulla:m k. I'. 
Lower I IOL - C and 1\pnlipoprotein A I Ur< 
related 10 higher s'om~mlar tillmtion rate in 
subjecL< wilhout kidney disense J lipul II•• 
2010:5 IY~2-I V90 
16 Ubs. 1.1 .. ljonu C.K.. The llnormity of 22 
chroftic kidney d.tseas.t in Nigtria. The 
situation wn • Teniary Hospill.l in South East 
NistriaJ1lvp Med 1010; Artlcle/D so 19J7:6 
1\g<>oo E.l . Uut;uru M .. A;;>oo P.A •. Ansbal.o 
D .. "'""" hptd prolilc cf l'hg<rion diAb<uc.\ 
uoilb eod Mlgc renal d1~sc.~ n f.\/ Ajrl m.:d J 
21!QJ:U·JOJ.JM 
17 ljoma C., UlaSI 1 .. ljoma U .. lfebunondu N .. 
High prevnk'ncc' of annemio in prcdinlysis 
pulienlli in Enugu Nigtria Nephrolox.v RCI·icw 
2011;2 
18. Shiuu A.O.. Chijoke A.. Oiliominu SA, 
MakusKti AM., Sarutl M.A., Abdulraluuan 
M H., Hacmatologic profile In patienu with 
chronic kidocy diseosc in Nigrrio JNRT 
10/J;J:J.JO 
23. Bulum T . Kobric B., Prl<acin L Ou1•njak 1. .. 
Total tlnd LOL cholesterol arc associitcd 
withg lome rulnr fillration r-ate in 
l.h.trmo~lbuminurie T)•pe I diabeti\:S Coli 
A•orlu-.~•1/201J.J7 711-776 
24. S<idullah M. Rahman M.R., Begum S., Hoy01 
S., Khan A.S., Assocmlion brt.,.ttn HOL. ond 
reno! funclton in Type 2 diabeiEs ruefUl"' 
subj«IS tn • Bnnsl>deshi Population J £,.,,. 
M•dCo/1011, 1:/J./9 
14 
